In four of the tested post-transplantation relapse samples with decreased expression of MHC class II, the authors show that these samples did not stimulate third-party CD4+ T cells in vitro, suggesting that blocking the ability of the donor CD8+ and CD4+ T cells to recognize the leukemia target prevents recognition through failed antigen presentation [20]. The gene discussed is CD4; the disease is leukemia.